pre-seed
Stage
1
Investors
About
Sequence Bio uses population multi-omics data from genetically less variable populations in Newfoundland and Labrador to discover rare gene variants associated with diseases and collaborates with pharma and biotech companies to identify drug targets and optimize clinical trials.
Explore Sequence Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.